Skip to main content

Volitionrx Ltd

VNRX
Exchange
NYSE
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000093314

No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Volitionrx Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Volitionrx Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Volitionrx Ltd
NameTitleLast reported holdingLast filingFilings, past year
Forterre GaelChief Commercial Officer331,338Mar 19, 20268
Rootsaert Rodney GerardSecretary273,993Mar 19, 20268
Micallef Jacob VincentChief Scientific Officer572,179Mar 19, 20265
Plummer NicholasGC - Volition Diagnostics407,267Mar 19, 20267
Reynolds Cameron JohnPresident and CEO3,115,547Feb 27, 20264
Innes Guy ArchibaldDirector1,252,967Feb 27, 20263
Kway JasmineCEO - Singapore Volition418,614Feb 27, 20262
Hughes TerigChief Financial Officer684,970Feb 27, 20262
Nguyen KimDirector305,816Feb 27, 20262
Batchelor Ann-LouiseGroup Chief Marketing Officer324,072Feb 27, 20264
Rubin EthelDirector252,948Feb 27, 20262
Still Timothy IDirector1,625,458Jan 23, 20262
Colman AlanDirector257,364Jan 23, 20261
Barnes PhillipDirector67,368Jan 23, 20261
Butera Salvatore ThomasCEO - Volition Veterinary375,203Jan 23, 20264
Henshall MickieDirector44,206Jan 23, 20261
Retter AndrewChief Medical Officer146,568Nov 4, 20251
Gaetan MichelChief Operating Officer256,746Oct 7, 20252
Futcher EdwardDirector80,436Jan 26, 20240
Faulkes Martin CharlesExecutive Director1,740,207Jan 26, 20240
Hever Investments Ltd10% Owner298,419IndirectJan 3, 20240
Eight Corp Ltd10% Owner298,419IndirectJan 3, 20240
Brudnick RichardDirector27,936Jan 13, 20230
Terrell Jason Bradley MDChief Medical Officer2,326IndirectAug 5, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 17, 2025 (view filing)1:12 PM ETNov 17Same dayReynolds Cameron JohnPresident and CEOPPurchase+20.0K$0.35+$7.00K+0.8%2.55M after
Oct 15, 2025 (view filing)4:05 PM ETOct 141 dayReynolds Cameron JohnPresident and CEOPPurchase+110.0K$0.51+$56.1K+4.5%2.53M after
Oct 15, 2025 (view filing)4:05 PM ETOct 141 dayReynolds Cameron JohnPresident and CEOPPurchase+110.0K$0.01+$1.10K–110.0K afterDerivative
Oct 15, 2025 (view filing)4:05 PM ETOct 141 dayInnes Guy ArchibaldDirectorPPurchase+96.2K$0.51+$49.0K+9.9%1.06M after
Oct 15, 2025 (view filing)4:05 PM ETOct 141 dayInnes Guy ArchibaldDirectorPPurchase+96.2K$0.01+$961.53–96.2K afterDerivative
Oct 15, 2025 (view filing)4:05 PM ETOct 141 dayStill Timothy IDirectorPPurchase+48.1K$0.51+$24.5K+3.2%1.54M after
Oct 15, 2025 (view filing)4:05 PM ETOct 141 dayStill Timothy IDirectorPPurchase+48.1K$0.01+$480.76–48.1K afterDerivative
Sep 15, 2025 (view filing)Sep 123 daysReynolds Cameron JohnPresident and CEOPPurchase+15.0K$0.66+$9.90K+0.6%2.62M after
Aug 6, 2025 (view filing)Aug 51 dayInnes Guy ArchibaldDirectorPPurchase+78.1K$0.64+$50.0K+8.8%966.8K after
Aug 6, 2025 (view filing)Aug 51 dayReynolds Cameron JohnPresident and CEOPPurchase+78.1K$0.64+$50.0K+3.1%2.61M after
Jun 16, 2025 (view filing)Jun 124 daysReynolds Cameron JohnPresident and CEOPPurchase+12.5K$0.59+$7.38K+0.5%2.33M after
Jun 4, 2025 (view filing)Jun 31 dayInnes Guy ArchibaldDirectorPPurchase+20.0K$0.54+$10.8K+2.3%888.7K after
May 19, 2025 (view filing)1:23 PM ETMay 19Same dayMicallef Jacob VincentChief Scientific OfficerPPurchase+50.0K$0.43+$21.5K+13.3%426.0K after
May 19, 2025 (view filing)12:43 PM ETMay 19Same dayReynolds Cameron JohnPresident and CEOPPurchase+20.0K$0.4365+$8.73K+0.9%2.32M after
Mar 27, 2025 (view filing)Mar 261 dayReynolds Cameron JohnPresident and CEOPPurchase+181.8K$0.55+$100.0K+8.6%2.30M after
Mar 27, 2025 (view filing)Mar 261 dayInnes Guy ArchibaldDirectorPPurchase+181.8K$0.55+$100.0K+26.5%868.7K after
Dec 10, 2024 (view filing)Dec 91 dayInnes Guy ArchibaldDirectorPPurchase+174.8K$0.57+$99.6K+39.5%617.1K after
Dec 10, 2024 (view filing)Dec 91 dayStill Timothy IDirectorPPurchase+87.4K$0.57+$49.8K+6.2%1.49M after
Dec 10, 2024 (view filing)Dec 91 dayMicallef Jacob VincentChief Scientific OfficerPPurchase+43.7K$0.57+$24.9K+12.5%394.4K after
Dec 10, 2024 (view filing)Dec 91 dayReynolds Cameron JohnPresident and CEOPPurchase+139.8K$0.57+$79.7K+7.1%2.12M after
Aug 21, 2024 (view filing)Aug 201 dayInnes Guy ArchibaldDirectorPPurchase+150.0K$0.67+$100.5K+58.4%406.7K after
Jan 3, 2024 (view filing)10:41 AM ETJan 21 dayHever Investments Ltd and 1 other10% OwnerSSaleVOLITIONRX LTD−20.0K$0.90−$18.0K−6.3%298.4K after
Dec 20, 2023 (view filing)10:31 AM ETDec 155 daysLateHever Investments Ltd and 1 other10% OwnerSSale−20.0K$0.75−$15.0K−5.9%318.4K after
Dec 19, 2023 (view filing)Dec 181 dayButera Salvatore ThomasCEO - Volition VeterinaryPPurchase+10.0K$0.83+$8.30K+11.2%99.3K after
Dec 18, 2023 (view filing)Dec 153 daysButera Salvatore ThomasCEO - Volition VeterinaryPPurchase+10.0K$0.77+$7.70K+12.6%89.3K after
Dec 14, 2023 (view filing)Dec 131 dayRootsaert Rodney GerardSecretaryPPurchase+10.0K$0.60+$6.00K+14.6%78.7K after
Dec 11, 2023 (view filing)Dec 83 daysReynolds Cameron JohnPresident and CEOPPurchase+10.0K$0.67+$6.70K+0.6%1.70M after
Nov 28, 2023 (view filing)Nov 271 dayInnes Guy ArchibaldDirectorPPurchase+20.0K$0.77+$15.4K+3.3%627.2K after
Nov 28, 2023 (view filing)Nov 271 dayFutcher EdwardDirectorPPurchase+9.00K$0.80+$7.20K+14.3%71.9K after
Nov 27, 2023 (view filing)Nov 243 daysInnes Guy ArchibaldDirectorPPurchase+10.0K$0.76+$7.60K+1.7%607.2K after
Nov 24, 2023 (view filing)Nov 222 daysInnes Guy ArchibaldDirectorPPurchase+20.0K$0.71+$14.2K+3.5%597.2K after
Nov 17, 2023 (view filing)Nov 161 dayButera Salvatore ThomasCEO - Volition VeterinaryPPurchase+10.0K$0.81+$8.10K+14.4%79.3K after
Sep 19, 2023 (view filing)Aug 3119 daysLateHenshall MickieDirectorPPurchase+3.71K$1.25+$4.63K+24.7%18.7K after
Sep 6, 2023 (view filing)Sep 51 dayBarnes PhillipDirectorPPurchase+5.00K$1.30+$6.50K+25.4%24.7K after
Sep 1, 2023 (view filing)Aug 311 dayFaulkes Martin CharlesDirectorPPurchase+9.72K$1.28+$12.4K+0.6%1.67M after
Aug 31, 2023 (view filing)Aug 29-302 daysMicallef Jacob VincentChief Scientific OfficerPPurchase+20.0K$1.25+$25.1K+57.1%55.0K after2 lots
Aug 28, 2023 (view filing)Aug 253 daysMicallef Jacob VincentChief Scientific OfficerPPurchase+20.0K$1.24+$24.8K+9.3%235.1K after
Aug 25, 2023 (view filing)Aug 241 dayKway JasmineCEO - Singapore VolitionPPurchase+5.00K$1.20+$6.00K+92.6%10.4K after
Aug 25, 2023 (view filing)Aug 241 dayFutcher EdwardDirectorPPurchase+5.00K$1.22+$6.10K+8.6%62.9K after
Aug 24, 2023 (view filing)Aug 24Same dayGaetan MichelChief Operating OfficerPPurchase+5.00K$1.23+$6.15K+2.4%213.0K after
Aug 17, 2023 (view filing)Aug 161 dayButera Salvatore ThomasCEO - Volition VeterinaryPPurchase+8.00K$1.21+$9.68K+13.0%69.3K after
Aug 16, 2023 (view filing)Aug 16Same dayReynolds Cameron JohnPresident and CEOPPurchase+10.0K$1.22+$12.2K+0.7%1.49M after
Jun 6, 2023 (view filing)Jun 24 daysButera Salvatore ThomasCEO - Volition VeterinaryPPurchase+10.0K$1.59+$15.9K+19.5%61.4K after
Feb 23, 2023 (view filing)Feb 221 dayInnes Guy ArchibaldDirectorPPurchase+234.0K$1.75+$409.5KNew position154.5K after4 lots
Dec 20, 2022 (view filing)Dec 191 dayButera Salvatore ThomasCEO - Volition VeterinaryPPurchase+5.00K$2.27+$11.3K+10.8%51.4K after
Dec 20, 2022 (view filing)Dec 16-194 daysMicallef Jacob VincentChief Scientific OfficerPPurchase+32.3K$2.22+$71.9K+20.7%188.4K after2 lots
Dec 19, 2022 (view filing)Dec 163 daysFaulkes Martin CharlesDirectorPPurchase+55.0K$2.10+$115.5K+3.5%1.64M after
Dec 13, 2022 (view filing)Dec 121 dayButera Salvatore ThomasCEO - Volition VeterinaryPPurchase+4.35K$2.09+$9.09K+10.4%46.4K after
Dec 12, 2022 (view filing)Dec 84 daysPlummer NicholasGC - Volition DiagnosticsPPurchase+4.80K$2.07+$9.94K+10.3%51.5K after
Nov 29, 2022 (view filing)Nov 281 dayButera Salvatore ThomasCEO - Volition VeterinaryPPurchase+5.00K$2.21+$11.1K+13.5%42.0K after